Molecular mechanisms of primary hypercalciuria

Journal of the American Society of Nephrology

Volumn 14, Issue 4, 2003, Pages 1082-1095

  Frick, Kevin K ^a   Bushinsky, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM TRANSPORT; HENLE LOOP; HUMAN; HYPERCALCIURIA; INTESTINE ABSORPTION; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; NEPHROLITHIASIS; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW;

EID: 0037379519     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000062960.26868.17     Document Type: Review

References (151)

1. Bushinsky DA: Renal lithiasis. In: Kelly's Textbook of Medicine, edited by Humes HD, New York, Lippincott Williams & Wilkens, 2000, pp 1243-1248
2. Pak CY: Nephrolithiasis. Curr Ther Endo Metab 6: 572-576, 1997
3. Bushinsky DA: Nephrolithiasis. J Am Soc Nephrol 9: 917-924, 1998
4. Monk RD, Bushinsky DA: Nephrolithiasis and nephrocalcinosis. In: Comprehensive Clinical Nephrology, edited by Johnson R, Frehally J, London, Mosby, 2000, pp 973-989
5. Consensus Conference: Prevention and treatment of kidney stones. JAMA 260: 977-981, 1988
6. Pak CYC: Pathophysiology of calcium nephrolithiasis. In: The Kidney: Physiology and Pathophysiology, 2nd ed., edited by Seldin DW, Giebisch G, New York, Raven Press, Ltd., 1992, pp 2461-2480
7. Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med 327: 1141-1152, 1992
8. Asplin JR, Favus MJ, Coe FL: Nephrolithiasis. In: The Kidney, 6th ed., edited by Brenner BM, Philadelphia WB Saunders Company, 2000, pp 1774-1819
9. Monk RD, Bushinsky DA: Kidney stones. In: Williams Textbook of Endocrinology, 10th ed., edited by Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, Philadelphia WB Saunders, 2003, pp 1411-1425
10. Coe FL, Bushinsky DA: Pathophysiology of hypercalciuria. Am J Physiol (Renal Fluid Electrolyte Physiol) 247: F1-F13, 1984
11. Levy FL, Adams-Huet B, Pak CY: Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98: 50-59, 1995
12. Robertson WG, Morgan DB: The distribution of urinary calcium excretion in normal persons and stone-formers. Clin Chim Acta 37: 503-508, 1972
13. Bushinsky DA, Parker WR, Asplin JR: Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550-560, 2000
14. Mehes K, Szelid Z: Autosomal dominant inheritance of hypercalciuria. Eur J Pediatr 133: 239-242, 1980
15. Harangi F, Mehes K: Family investigatons in idiopathic hypercalciuria. Eur J Pediatr 152: 64-68, 1993
16. Bushinsky DA: Genetic hypercalciuric stone forming rats. Semin Nephrol 16: 448-457, 1996
17. Bushinsky DA: Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 8: 479-488, 1999
18. Polito C, La Manna A, Cioce F, Villani J, Nappi B, DiToro R: Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 15: 211-214, 2000
19. Coe FL, Parks JH, Moore ES: Familial idiopathic hypercalciuria. N Engl J Med 300: 337-340, 1979
20. Bushinsky DA, Favus MJ: Mechanism of hypercalciuria in genetic hypercalciuric rats: Inherited defect in intestinal calcium transport. J Clin Invest 82: 1585-1591, 1988
21. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA: Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43: 189-196, 1993
22. Li X-Q, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ: Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of intestinal calcium hyperabsorption. J Clin Invest 91: 661-667, 1993
23. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL: Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45: 58-65, 1994
24. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL: Stone formation in genetic hypercalciuric rats. Kidney Int 48: 1705-1713, 1995
25. 3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol) 271: C130-C135, 1996
26. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD: Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55: 602-612, 1999
27. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL: Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51: 640-645, 1997
28. Tsuruoka S, Bushinsky DA, Schwartz GJ: Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51: 1540-1547, 1997
29. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS: Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234-243, 1999
30. 3: A new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101: 2223-2232, 1998
31. Bushinsky DA, Grynpas MD, Asplin JR: Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59: 1415-1423, 2001
32. Bushinsky DA: Calcium, magnesium, and phosphorus: Renal handling and urinary excretion. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed., edited by Favus MJ, Philadelphia, Lippincott Williams & Wilkins, 1999, pp 67-74
33. Bushinsky DA: Disorders of calcium and phosphorus homeostasis. In: Primer on Kidney Diseases, 3rd ed., edited by Greenberg A, San Diego, Academic Press, 2001, pp 107-115
34. Coe FL, Parks JH: Familial (idiopathic) hypercalciuria. In: Nephrolithiasis: Pathogenesis and Treatment, 2nd ed., edited by Coe FL, Parks JH, Chicago, Year Book Medical Publishers, Inc., 1990, pp 108-138
35. Bronner F, Pansu D: Nutritional aspects of calcium absorption. J Nutr 129: 9-12, 1999
36. Bronner F, Pansu D, Stein WD: An analysis of intestinal calcium transport across the rat intestine. Am J Physiol (Gastroint and Liver Physiol) 250: G561-G569, 1986
37. 3. Arch Biochem Biophys 202: 235-241, 1980
38. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA: Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274: 22739-22746, 1999
39. 3-responsive epithelia. J Biol Chem 274: 8375-8378, 1999
40. Feher JJ, Fullmer CS, Wasserman RH: Role of facilitated diffusion of calcium by calbindin in intestinal calcium absorption. Am J Physiol 262: C517-C526, 1992
41. 2+-binding protein. Am J Physiol 251: G223-G229, 1986
42. Wasserman RH, Chandler JS, Meyer SA, Smith CA, Brindak ME, Fullmer CS, Penniston JT, Kumar R: Intestinal calcium transport and calcium extrusion processes at the basolateral membrane. J Nutr 122: 662-671, 1992
43. Birnbaumer L, Zhu X, Jiang M, Boulay G, Peyton M, Vannier B, Brown D, Platano D, Sadeghi H, Stefani E, Birnbaumer M: On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc Natl Acad Sci USA 93: 15195-15202, 1996
44. Muller D, Hoenderop JG, Merkx GF, Van Os CH, Bindels RJ: Gene structure and chromosomal mapping of human epithelial calcium channel. Bioch Biophys Res Commun 275: 47-52, 2000
45. Barley NF, Howard A, O'Callaghan D, Legon S, Walters JR: Epithelial calcium transporter expression in human duodenum. Am J Physiol Gastrointest Liver Physiol 280: G285-G290, 2001
46. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillion R, Carmeliet G: Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Acad Sci USA 98: 13324-13329, 2001
47. 2+ reabsorption in the distal nephron. Annu Rev Physiol 64: 529-549, 2002
48. 2+ channel in rabbit kidney and intestine. J Am Soc Nephrol 11: 1171-1178, 2000
49. Bushinsky DA, Monk RD: Calcium. Lancet 352: 306-311, 1998
50. Scott P, Ouimet D, Valiquette L, Guay G, Proulx Y, Trouve ML, Gagnon B, Bonnardeaux A: Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Neph 10: 1007-1013, 1999
51. Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW: Familial calcium stone disease: Taq1 polymorphism and the vitamin D receptor. J Endourol 13: 313-316, 1999
52. Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CY: Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 80: 2960-2965, 1995
53. 3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24: 307-313, 1998
54. Imamura K, Tonoki H, Wakui K, Fukushima Y, Sasaki S, Yausda K, Takekoshi Y, Tochimaru H: 4q33-qter deletion and absorptive hypercalciuria: report of two unrelated girls. Am J Med Genet 78: 52-54, 1998
55. 2+ channel (ECAC1). Genomics 67: 48-53, 2000
56. 2+-transporting ATPases to human chromosomes 1q25-32 and 12q2123. Genomics 9: 629-641, 1991
57. 9k gene: Complete structure and implications on steroid hormone regulation. J Mol Biol 235: 1231-1238, 1994
58. Reed BY, Heller HJ, Gitomer WL, Pak CY: Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 84: 3907-3913, 1999
59. Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lemke M, Padalino P, Pak CY: Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87: 1476-1485, 2002
60. Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, et al: "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets: Two phenotypical expressions of a common genetic defect. N Engl J Med 316: 125-129, 1987
61. Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS: Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95: 5372-5377, 1998
62. Tenenhouse HS, Gauthier C, Martel J, Hoenderop JG, Hartog A, Meyer MH, Meyer RAJr, Bindels RJ: Na/Pi cotransporter (Npt2) gene disruption increases duodenal calcium absorption and expression of epithelial calcium channels 1 and 2. Pflugers Arch 444: 670-676, 2002
63. Jones A, Tzenova J, Frappier D, Crumley M, Roslin N, Kos C, Tieder M, Langman C, Proesmans W, Carpenter T, Rice A, Anderson D, Morgan K, Fujiwara T, Tenenhouse H: Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na/Pi cotransporter NPT2 gene. J Am Soc Nephrol 12: 507-514, 2001
64. van den Heuvel L, Op de Koul K, Knots E, Knoers N, Monnens L: Autosomal recessive hypophosphataemic rickets with hypercalciuria is not caused by mutations in the type II renal sodium/ phosphate cotransporter gene. Nephrol Dial Transplant 16: 48-51, 2001
65. Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp G, Friedlander G: Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Eng J Med 347: 983-991, 2002
66. Jan de Beur SM, Levine MA: Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87: 2467- 2473, 2002
67. The HYP Consortium: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11: 130-136, 1995
68. Fukumoto S, Yamashita T: Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Current Opin in Nephrol Hypertens 11: 385-389, 2002
69. Schiavi SC, Moe OW: Phosphatonins: A new class of phosphate-regulating proteins. Curr Opin Nephrol Hypertens 11: 423-430, 2002
70. Econs MJ, McEnery PT, Lennon F, Speer MC: Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100: 2653-2657, 1997
71. The ADHR Consortium: Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26: 345-348, 2000
72. White KE, Jonsson KB, Cam G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ: The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86: 497-500, 2001
73. Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC: FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Bioch Biophys Res Commun 284: 977-981, 2001
74. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S: Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87: 4957-4960, 2002
75. Kumar R: New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia. Curr Opin Nephrol Hypertens 11: 547-553, 2002
76. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ: Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci USA 99: 11470-11475, 2002
77. Dent CE, Friedman M: Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 39: 240-249, 1964
78. Pook MA, Wrong O, Wooding C, Norden AG, Feest TG, Thakker RV: Dent's disease, a renal Fanconi syndrome with nephrocalcinosis and kidney stones, is associated with a microdeletion involving DXS255 and maps to Xp11.22. Hum Mol Genet 2: 2129-2134, 1993
79. Fisher SE, Black GC, Lloyd SE, Hatchwell E, Wrong O, Thakker RV, Craig IW: Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis). Hum Mol Genet 3: 2053-2059, 1994
80. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV: A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449, 1996
81. Igarashi T, Gunther W, Sekine T, Inatomi J, Shiraga H, Takahashi S, Suzuki J, Tsuru N, Yanagihara T, Shimizu M, Jentsch TJ, Thakker RV: Functional characterization of renal chloride channel. CLCN 5: Mutations associated with Dent's Japan disease. Kidney Int 54: 1850-1856, 1998
82. Thakker RV: Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis. Kidney Int 57: 787-793, 2000
83. Silva IV, Morales MM, Lopes AG: CIC-5 chloride channel and kidney stones: What is the link? Braz J Med Biol Res 34: 315-323, 2001
84. Jentsch TJ, Stein V, Weinreich F, Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev 82: 503-568, 2002
85. Luyckx VA, Goda FO, Mount DB, Nishio T, Hall A, Hebert SC, Hammond TG, Yu AS: Intrarenal and subcellular localization of rat CLC5. Am J Physiol 275: F761-F769, 1998
86. Luyckx VA, Leclercq B, Dowland LK, Yu AS: Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. Proc Natl Acad Sci USA 96: 12174-12179, 1999
87. -: Channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373, 2000
88. Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ: CIC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA 95: 8075-8080, 1998
89. 3. Cell 96: 507-515, 1999
90. Leheste JR, Rolinski B, Vorum H, Hilpert J, Nykjaer A, Jacobsen C, Aucouturier P, Moskaug JO, Otto A, Christensen EI, Willnow TE: Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Path 155: 1361-1370, 1999
91. Leheste JR, Melsen F, Wellner M, Jansen P, Schlichting U, Renner-Muller I, Andreassen TT, Wolf E, Bachmann S, Nykjaer A, Willnow TE: Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17: 247-249, 2003
92. Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, Guggino WB: Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9: 2937-2945, 2000
93. Yu AS: Role of CIC-5 in the pathogenesis of hypercalciuria: recent insights from transgenic mouse models. Curr Opin Nephrol Hypertens 10: 415-420, 2001
94. Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, Hebert SC: Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 269: 17713-17722, 1994
95. Haas M, Forbush B3: The Na-K-Cl cotransporters. J Bioenerg Biomembr 30: 161-172, 1998
96. Bartter FC, Pronove P, Gill JR, MacCardle RC: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hyperkalemic alkalosis. Am J Med 33: 811-828, 1962
97. Pearce SH: Straightening out the renal tubule: Advances in the molecular basis of the inherited tubulopathies. Q J Med 91: 5-12, 1998
98. Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG: Genetic disorders of renal electrolyte transport. N Eng J Med 340: 1177-1187, 1999
99. Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K: Congenital hypokalemia with hypercalciuria in preterm infants: A hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107: 694-701, 1985
100. Guay-Woodford LM: Bartter syndrome: Unraveling the pathophysiologic enigma. Am J Med 105: 151-161, 1998
101. Kockerling A, Reinalter SC, Seyberth HW: Impaired respose to furosemide in hyperprostaglandin E Syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr 129: 519-528, 1996
102. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP: Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K2Cl cotransporter NKCC2. Nat Genet 13: 183-188, 1996
103. + channel. ROMK. Nat Genet 14: 152-156, 1996
104. International collaborative study group for Bartter-like syndromes: Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity. Hum Mol Genet 6: 17-26, 1997
105. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriquez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17: 171-178, 1997
106. Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschenes G, Antignac C, Guay-Woodford LM, Knoers NV, Seyberth HW, Feldman D, Hildebrandt F: Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 11: 1449-1459, 2000
107. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, Hebert SC: Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92: 131-135, 1995
108. 2+-sensing receptor and PTH/ PTHrP receptor in rat kidney. Am J Physiol 271: F951-F956, 1996
109. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperpathyroidism. Cell 75: 1297-1303, 1993
110. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol. 200: 295-302, 1997
111. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV: A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Eng J Med 335: 1115-1122, 1996
112. Thakker RV: Disorders of the calcium-sensing receptor. Biochim Biophys Acta 1448: 166-170, 1998
113. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Bianchi G, Brandi ML: Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 13: 2517-2523, 2002
114. 2+ resorption. Science 285: 103-106, 1999
115. Mitic LL, Van Itallie CM, Anderson JM: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: Lessons from mutant animals and proteins. Am J Physiol (Gastroint Liver Physiol) 279: G250-G254, 2000
116. Weber S, Hoffmann K, Jeck N, Saar K, Boeswald M, Kuwertz-Broeking E, Meij II, Knoers NV, Cochat P, Sulakova T, Bonzel KE, Soergel M, Manz F, Schaerer K, Seyberth HW, Reis A, Konrad M: Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet 8: 414-422, 2000
117. Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P: Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59: 2206- 2215, 2001
118. Reilly RF, Ellison DH: Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 80: 277- 313, 2000
119. 2+ channel family: Comparison of mammalian ECaCl and 2. J Physiol 537: 747-761, 2001
120. Peng JB, Chen XZ, Berger UV, Weremowwicz S, Morton CC, Vassilev PM, Brown EM, Hediger MA: Human calcium transport protein CAT1. Bioch Biophys Res Commun 278: 326-332, 2000
121. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA: A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem 275: 28186-28194, 2000
122. Peng JB, Brown EM, Hediger MA: Structural conservation of the genes encoding CAT1, CaT2, and related cation channels. Genomics 76: 99-109, 2001
123. Suzuki M, Ishibashi K, Ooki G, Tsuruoka S, Imai M: Electrophysiologic characteristics of the Ca-permeable channels, ECaC and CaT, in the kidney. Bioch Biophys Res Commun 274: 344-349, 2000
124. Loffing J, Loffing-Cueni D, Valderrabano V, Klausli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B: Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 281: F1021-F1027, 2001
125. 9k and parvalbumin are exclusively located along basolateral membranes in rat distal nephron. J Am Soc Nephrol 2: 1122-1129, 1991
126. 28K gene. Proc Natl Acad Sci USA 94: 1488-1493, 1997
127. 3 in the kidney. Curr Opin Nephrol Hypertens 9: 341-347, 2000
128. Shimizu T, Yoshitomi K, Nakamura M, Imai M: Effects of PTH, calcitonin, and cAMP on calcium transport in rabbit distal nephron segments. Am J Physiol 259: F408-F414, 1990
129. 3 and PTH. Am J Physiol 261: F799-F807, 1991
130. Hoenderop JG, Muller D, van der Kemp AW, Hartog A, Suzuki M, Ishibashi K, Imai M, Sweep F, Willems PH, Van Os CH, Bindels RJ: Calcitriol controls the epithelial calcium channel in kidney. J Am Soc Nephrol 12: 1342-1349, 2001
131. Pietschmann F, Breslau NA, Pak CYC: Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7: 1383-1388, 1992
132. Jaeger P, Lippuner K, Casez JP, Hess B, Ackerman D, Hug C: Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Min Res 9: 1525-1532, 1994
133. Giannini S, Nobile M, Sartori L, Calo L, Tasca A, Dalle Carbonare L, Ciuffreda M, D'Angelo A, Pagano F, Crepaldi G: Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50: 94-100, 1998
134. Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V: Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57: 183- 191, 2002
135. Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S: Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 59: 865-869, 2002
136. Heilberg IP, Martini LA, Teixeira SH, Szejnfeld VL, Carvalho AB, Lobao R, Draibe SA: Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia. Nephron 79: 430-437, 1998
137. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Eng J Med 346: 77-84, 2002
138. Bushinsky DA: Recurrent hypercalciuric nephrolithiasis - Does diet help? N Eng J Med 346: 124-125, 2002
139. Pak CYC, McGuire J, Peterson R, Britton F, Harrod MJ: Familial absorptive hypercalciuria in a large kindred. J Urology 126: 717-719, 1981
140. Favus MJ, Coe FL: Evidence for spontaneous hypercalciuria in the rat. Mineral Electrolyte Met 2: 150-154, 1979
141. Bushinsky DA: Bench to bedside: Lessions from the genetic hypercalciuric stone froming rat. Am J Kidney Dis 36: 61-64, 2000
142. Monk RD, Bushinsky DA: Pathogenesis of idiopathic hypercalciuria. In: Kidney Stones: Medical and Surgical Management, edited by Coe F, Favus M, Pak C, Parks J, Preminger G, Philadelphia, Lippincott-Raven, 1996, pp 759-772
143. Favus MJ: Hypercalciuria: Lessons from studies of genetic hypercalciuric rats. J Am Soc Nephrol 5: S54-S58, 1994
144. Pols HAP, Birkenhager JC, Schilte JP, Visser TJ: Evidence that self-induced metabolism of 1,25-dihydroxyvitamin D3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells. Biochim Biophys Acta 970: 122-129, 1988
145. Reinhardt TA, Horst RL: Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness. J Biol Chem 264: 15917-15921, 1989
146. Favus MJ, Mangelsdorf DJ, Tembe V, Coe BJ, Haussler MR: Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat. J Clin Invest 82: 218-224, 1988
147. 3 up-regulates the 1,25 dihydroxyvitamin D3 receptor in vivo. Proc Natl Acad Sci USA 86: 9770-9773, 1989
148. 3 receptor concentration in rat kidney in vivo. Proc Natl Acad Sci USA 87: 4312-4314, 1990
149. 3 and dexamethasone on rat osteoblast-like primary cell cultures: Receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology 118: 250-259, 1986
150. 3 receptors by analogs in cultured mammalian cells. Endocrinology 117: 2203-2210, 1985
151. Bushinsky DA, Krieger NS: Role of the skeleton in calcium homeostasis. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW, Giebisch G, New York, Raven Press, 1992, pp 2395-2430